Joint Stock Co Pharmstandard Public is 10% Owner at ARGOS THERAPEUTICS INC (ARGS). They have made 9 open-market trades across 2 companies since 2014, most recently 2017-06-21.
CIK 0001598754
9 open-market purchases totalling $18.3M since 2014, never a sale. Across 9 scored buys the stock is up 5.5% at ninety days, and 2.2 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 22% | 56% |
| Avg Move | -2.4% | -2.6% | +5.5% |
| Alpha | -1.1% | -2.1% | +2.2% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARGS | BUY | 2016-10-07 | 2016-10-13 | $4.73 | $99K | +0.0% | +6.6% | +22.0% |
| ARGS | BUY | 2016-10-04 | 2016-10-13 | $4.73 | $150K | +0.0% | +6.6% | +22.0% |
| ARGS | BUY | 2016-09-30 | 2016-10-04 | $4.71 | $391K | -2.9% | -14.7% | +4.2% |
| ARGS | BUY | 2016-09-19 | 2016-09-21 | $4.77 | $420K | -9.6% | -10.5% | -8.0% |
| ARGS | BUY | 2016-09-15 | 2016-09-20 | $4.77 | $501K | +1.0% | -4.1% | -1.4% |
| ARGS | BUY | 2016-08-24 | 2016-08-25 | $4.55 | $263K | +16.6% | -0.4% | +8.6% |
| ARGS | BUY | 2016-08-23 | 2016-08-25 | $4.52 | $305K | +16.6% | -0.4% | +8.6% |
| PRTO | BUY | 2014-10-27 | 2014-10-29 | $10.00 | $6.0M | -29.4% | -6.4% | -6.4% |
| ARGS | BUY | 2014-02-12 | 2014-02-12 | $8.00 | $10.2M | -13.6% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.